Sign in
4

Changes in Ownership

Bionano Genomics, Inc. Filed Acc 0001209191-22-010048

Options or other derivatives

  • Chief Operating Officer acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

OLDAKOWSKI MARK · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +650,000 650,000 D
Loading xslF345X03/doc4.xml…